Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z H Gu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Applied Optics|September 8, 2010
Coherence in the single and multiple scattering of light from randomly rough surfacesZ H Gu, J Q Lu, A A Maradudin, et al.
Applied Optics|August 14, 2010
Enhanced transmission through rough-metal surfacesZ H Gu, R S Dummer, A A Maradudin, et al.
Zhonghua Yi Xue Za Zhi|January 22, 2016
[Relationship between interleukin-8 levels in expressed prostatic secretion and expressions of bFGF and Bcl-2 in benign prostatic hyperplasia]W Song, D Y Li, H C Yuan, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|June 8, 2021
[Logistic regression analysis of risk factors for subretinal fluid after rhegmatogenous retinal detachment repair]Y Fu, Y L Zhang, L Y Li, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|October 1, 1985
[Controlled hypotensive anesthesia in cleft palate surgery]Z H Gu, G An, K Y Liu, et al.
Clinical Radiology|April 3, 2026
Thrombectomy versus conservative treatment for medium vessel occlusion ineligible for intravenous thrombolysis: effect modified by stroke severityDi Hu, M Yang, Z-H Gu, et al.
Acta Pharmacologica Sinica|December 26, 2001
PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterizationY P Li, Z H Zhou, Y Y Pei, et al.
Applied Optics|August 25, 2010
Interaction of two optical beams at a symmetric random surfaceZ H Gu, H M Escamilla, E R Méndez, et al.
Acta Pharmacologica Sinica|December 19, 2001
PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potencyY P Li, Y Y Pei, J Ding, et al.
Biological & Pharmaceutical Bulletin|June 20, 2001
PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effectsY P Li, Y Y Pei, Z H Zhou, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Applied Optics|September 8, 2010
Coherence in the single and multiple scattering of light from randomly rough surfacesZ H Gu, J Q Lu, A A Maradudin, et al.
Applied Optics|August 14, 2010
Enhanced transmission through rough-metal surfacesZ H Gu, R S Dummer, A A Maradudin, et al.
Zhonghua Yi Xue Za Zhi|January 22, 2016
[Relationship between interleukin-8 levels in expressed prostatic secretion and expressions of bFGF and Bcl-2 in benign prostatic hyperplasia]W Song, D Y Li, H C Yuan, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|June 8, 2021
[Logistic regression analysis of risk factors for subretinal fluid after rhegmatogenous retinal detachment repair]Y Fu, Y L Zhang, L Y Li, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|October 1, 1985
[Controlled hypotensive anesthesia in cleft palate surgery]Z H Gu, G An, K Y Liu, et al.
Clinical Radiology|April 3, 2026
Thrombectomy versus conservative treatment for medium vessel occlusion ineligible for intravenous thrombolysis: effect modified by stroke severityDi Hu, M Yang, Z-H Gu, et al.
Acta Pharmacologica Sinica|December 26, 2001
PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterizationY P Li, Z H Zhou, Y Y Pei, et al.
Applied Optics|August 25, 2010
Interaction of two optical beams at a symmetric random surfaceZ H Gu, H M Escamilla, E R Méndez, et al.
Acta Pharmacologica Sinica|December 19, 2001
PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potencyY P Li, Y Y Pei, J Ding, et al.
Biological & Pharmaceutical Bulletin|June 20, 2001
PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effectsY P Li, Y Y Pei, Z H Zhou, et al.
Pageof 4